Squamous cell carcinoma of the head and neck: Diffusion-weighted MR imaging for prediction and monitoring of treatment response

European Radiology

Volumn 20, Issue 9, 2010, Pages 2213-2220

  King, Ann D ^a   Mo, Frankie K F ^b   Yu, Kwok Hung ^b   Yeung, David K W ^a   Zhou, Hua ^c   Bhatia, Kunwar S ^a   Tse, Gary M K ^a   Vlantis, Alexander C ^a   Wong, Jeffrey K T ^a   Ahuja, Anil T ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Chemoradiotherapy; Diffusion weighted imaging (DWI); Head and neck squamous cell carcinoma (HNSCC); MRI; Treatment response

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; CARCINOMA, SQUAMOUS CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77957951537     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1769-8     Document Type: Article

References (25)

1. McCollum AD, Burrell SC, Haddad RI et al (2004) Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26:890-896
2. Rogers JW, Greven KM, McGuirt WF et al (2004) Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58:694-697
3. Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusionweighted echo-planar MR imaging. Radiology 220:621-630
4. Maeda M, Kato H, Sakuma H et al (2005) Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. Am J Neuroradiol 26:1186-1192
5. Sumi M, Sakihama N, Sumi T et al (2003) Discrimination of metastatic cervical lymph nodes with diffusionweighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 24:1627-1634
6. Habermann CR, Gossrau P, Graessner J et al (2005) Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 177:940-945
7. King AD, Ahuja AT, Yeung DKW et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of MR diffusion weighted imaging (DWI). Radiology 245:806-813
8. Vandecaveye V, De Keyzer F, Vander Poortan V et al (2009) Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 251:134-146
9. de Bondt RB, Hoeberigs MC, Nelemans PJ et al (2009) Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 51:183-192
10. Holzapfel K, Duetsch S, Fauser C et al (2009) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 72:381-387
11. Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986-994
12. Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960-971
13. Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146-1152
14. Som PM (1987) Lymph nodes of the Neck. Radiology 165:593-600
15. Van der Brekel MWM, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379-384
16. Chenevert TL, Stegman LD, Taylor JM et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92:2029-2036
17. Pickles MD, Gibbs Peter, Lowry M et al (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843-847
18. Moffat BA, Chenevert TL, Meyer CR et al (2006) The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 8:259-267
19. Mardor Y, Pfeffer R, Spiegelmann R et al (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094-1100
20. Sharma U, Danishad KK, Seenu V et al (2009) Longitudinal study of the assessment by MRI and diffusionweighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 22:104-103
21. Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831-837
22. Zhao M, Pipe JG, Bonnett J et al (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73:61-64
23. Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7:779-787
24. Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3:1457-1466
25. Lee KC, Hall DE, Hoff BA et al (2006) Dynamic imaging of emerging resistance during cancer therapy. Cancer Res 66:4687-4692